ClinicalTrials.gg
Sign In

Menorrhagia clinical trials

The registry lists 206 studies for Menorrhagia across more than 10 countries. 35 are recruiting or about to start. 119 of them are mainly about Menorrhagia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Menorrhagia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
113
Status unknown
24
Recruiting
23
Terminated
21
Not yet recruiting
12
Withdrawn
8

Phase

Phase 3
45
Phase 4
26
Phase 2
13
Phase 1
5
Early Phase 1
2

Where

United States
85
Canada
17
Netherlands
12
China
12
United Kingdom
12
Mexico
9

Who runs them

Bayer (19) · Assiut University (8) · AbbVie (8) · Abbott (7) · Ferring Pharmaceuticals (5) · Minerva Surgical, Inc. (5) · Gynesonics (5) · Myovant Sciences GmbH (5)

What is being tested here

Drugs under test in Menorrhagia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tranexamic Acid2513
Relugolix155
Calcium Dobesilate112
Cyclobenzaprine101
Ginger extract101
Ferrosoferric Oxide101
Elagolix047
Asoprisnil067
Levonorgestrel045
Estradiol034

Drug classes tested here Hormonal contraceptives 16 · NSAIDs 3

Coming up

3phase 3 studies under way
11studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 23 Menorrhagia studies recruiting now, 4 (17%) set no upper age limit and 19 (83%) stop at 75 or younger. 5 (22%) take children under 18. 22 (96%) are for women only and 0 (0%) for men only; 5 (22%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
103 (13%)1 (4%)
1814 (61%)1 (4%)
3016 (70%)0 (0%)
4019 (83%)0 (0%)
5015 (65%)0 (0%)
655 (22%)0 (0%)
754 (17%)0 (0%)
854 (17%)0 (0%)

Across all 206 studies, recruiting or not: 70% stop at 75 or younger and 69% at 65; 15% take children; 95% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Menorrhagia studies take

Of 17 phase 3 interventional studies under Menorrhagia, half reached primary completion within 27 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 327 mo24–35 · 17 studies——
Interventional, no phase24 mo14–35 · 23 studies——
Observational61 mo41–102 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 206. Browse all 206 → or search them.